Dose-Efficient X-Ray Imaging Method Produces Micrometer Resolution Images of Biopsy Samples
By LabMedica International staff writers Posted on 20 Dec 2023 |

X-ray imaging plays a vital role in revealing the hidden structures and processes within living cells and organisms. However, the ionizing nature of X-ray radiation, composed of high-energy electromagnetic waves, poses a risk of damaging DNA, which in turn limits the duration of observation. Traditional X-ray imaging of soft tissues often results in low-contrast images, but phase contrast methods have been found to yield much clearer contrasts at lower radiation doses. However, achieving higher resolution in X-ray imaging is challenging due to the need for increased radiation dose, which is compounded by the reduced efficiency of high-resolution detectors, leading to further increase in radiation exposure. Until now, high-resolution X-ray phase contrast imaging of living biological samples could only be performed for a limited time before radiation caused significant damage.
At the Karlsruhe Institute of Technology (KIT, Karlsruhe, Germany), a team of researchers has innovated a technique that utilizes radiation more effectively and achieves micrometer-level resolution imaging. This method is suitable for observing both living organisms and delicate materials, opening new possibilities in fields like biology, biomedicine, and materials science. The novel system integrates X-ray phase contrast imaging with a Bragg magnifier and a photon-counting detector. In this setup, a photon-counting detector with 55-micrometer pixel size is used, and before capturing the specimen’s X-ray image, it is magnified using a Bragg magnifier. This magnification process allows the specimen's resolution to reach approximately 1 micrometer. The Bragg magnifier itself comprises two perfectly aligned silicon crystals, where the magnification effect is derived from asymmetric diffraction in the crystal lattice of silicon. A significant benefit of this Bragg magnifier is its exceptional optical image transmission, enabling almost complete replication of all spatial frequencies up to the resolution limit.
By combining propagation-based X-ray phase contrast with a Bragg magnifier and a photon-counting detector, all fine-tuned for 30 keV X-ray energy, the method achieves near-maximal dose efficiency for X-ray phase contrast imaging. This advancement permits extended observation periods of small living organisms with detailed micrometer resolution. The team showcased this technique in a preliminary study on tiny parasitic wasps, observing their activities inside host eggs and their emergence over more than 30 minutes. Future plans involve enhancing the setup to expand the field of view and boost mechanical stability, thereby enabling even longer measurement durations.
“Instead of converting the X-ray image into an image with visible light and enlarging it afterwards, we enlarge it directly,” said LAS doctoral researcher Rebecca Spiecker. “Thanks to this approach, we can use highly efficient large-area detectors. The method is also suited for biomedical applications, an example being the gentle three-dimensional histological investigation of biopsy samples.”
Related Links:
KIT
Latest Pathology News
- Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
- New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
- "Metal Detector" Algorithm Hunts Down Vulnerable Tumors
- Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
- Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
- AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
- AI Model Predicts Patient Response to Bladder Cancer Treatment
- New Laser-Based Method to Accelerate Cancer Diagnosis
- New AI Model Predicts Gene Variants’ Effects on Specific Diseases
- Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
- Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples
- 3D Cell Culture System Could Revolutionize Cancer Diagnostics
- Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves
- Skin-Based Test to Improve Diagnosis of Rare, Debilitating Neurodegenerative Disease
- Serum Uromodulin Could Indicate Acute Kidney Injury in COVID-19 Patients
- AI Model Reveals True Biological Age From Five Drops of Blood
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more